Introduction: Cervical cancer is the third most common malignant neoplasm affecting the female population in the Americas, with approximately half of the affected women succumbing to the disease. Low-income countries are the hardest hit, primarily due to inequalities in screening services and treatment of precancerous lesions, as well as in vaccination coverage against human papillomavirus (HPV). In this context, it is essential to accurately outline the mortality scenario due to cervical cancer in underdeveloped regions such as Northern Brazil, as current studies still lack information about this historically neglected territory that has been significantly impacted by the pathology in question. Objectives: To describe and analyze the number of deaths resulting from cervical cancer in Northern Brazil between 2019 and 2023. Methods: An epidemiological, cross-sectional, descriptive, and retrospective study. Secondary data from the Mortality Information System (SIM), made available by the Department of Information Technology of the Unified Health System (DATASUS), were used. The study analyzed deaths from cervical cancer in the Northern Region of Brazil from 2019 to 2023, based on the variables of place of residence, year of occurrence, age group, ethnicity, and education. The data were then organized and tabulated using Microsoft Excel 2021 software. Mean and percentile calculations were applied for data analysis. Results: Between 2019 and 2023, there were 4,496 deaths from malignant neoplasm of the cervix in the North region of Brazil, with the highest number of cases in the state of Pará, totaling 1,887 (41,9%), followed by the state of Amazonas, with 1,393 cases (30,98%), being the two states with the largest population. Regarding the year, the most notable was 2023, which presented 936 deaths (20,8%) from cervical cancer. When it comes to the most affected age group, women aged 40 to 49 were the most affected, with 1,080 (24%) occurrences. In addition, the brown color was the most affected by this neoplasm, corresponding to 3,365 (74.84%) deaths during the period analyzed. Regarding the education variable, it was found that 1,288 (28.64%) had completed 8 to 11 years of education, with the most prevalent education among cases of mortality from cervical cancer, followed by 4 to 7 years of education, which corresponds to 1,053 (23.42%) of the cases analyzed in the North region during the period determined in this study. Conclusion: From this, it can be concluded that cervical cancer is one of the main causes of death among women in the North region, with 2023 being the year with the highest occurrences. It is noted that brown women are the most affected, representing 74.84% of deaths during the period analyzed. In view of this, it can be explained by the fact the inequality in access to screening and treatments is a problem that must be addressed by the country's public policies to reverse this reality, since this neoplasm is highly preventable and curable when managed correctly.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
